Agilon Health, Inc. (NYSE:AGL) Sees Significant Growth in Short Interest

Agilon Health, Inc. (NYSE:AGL) was the target of a significant growth in short interest during the month of February. As of February 27th, there was short interest totaling 24,591,484 shares, a growth of 20.5% from the February 12th total of 20,413,986 shares. Based on an average daily trading volume, of 7,495,718 shares, the short-interest ratio is presently 3.3 days. Approximately 6.1% of the shares of the company are sold short. Approximately 6.1% of the shares of the company are sold short. Based on an average daily trading volume, of 7,495,718 shares, the short-interest ratio is presently 3.3 days.

Agilon Health Stock Performance

NYSE AGL opened at $0.61 on Wednesday. The stock has a market capitalization of $254.73 million, a price-to-earnings ratio of -0.65 and a beta of 0.11. The business’s 50 day moving average is $0.69 and its two-hundred day moving average is $0.80. Agilon Health has a 12-month low of $0.34 and a 12-month high of $6.08. The company has a current ratio of 1.02, a quick ratio of 1.02 and a debt-to-equity ratio of 0.12.

Agilon Health (NYSE:AGL) last posted its quarterly earnings results on Wednesday, February 25th. The company reported ($0.46) EPS for the quarter, missing the consensus estimate of ($0.27) by ($0.19). Agilon Health had a negative net margin of 6.60% and a negative return on equity of 120.82%. The business had revenue of $1.57 billion during the quarter, compared to analyst estimates of $1.46 billion. Research analysts expect that Agilon Health will post -0.59 EPS for the current year.

Hedge Funds Weigh In On Agilon Health

A number of institutional investors and hedge funds have recently made changes to their positions in the stock. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. increased its position in Agilon Health by 3.5% during the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 214,200 shares of the company’s stock worth $927,000 after purchasing an additional 7,209 shares during the last quarter. Dynamic Technology Lab Private Ltd boosted its holdings in shares of Agilon Health by 28.4% in the 1st quarter. Dynamic Technology Lab Private Ltd now owns 47,111 shares of the company’s stock valued at $204,000 after purchasing an additional 10,424 shares during the last quarter. Apollon Wealth Management LLC grew its stake in shares of Agilon Health by 17.4% during the 4th quarter. Apollon Wealth Management LLC now owns 82,348 shares of the company’s stock valued at $57,000 after buying an additional 12,193 shares during the period. Arrowpoint Investment Partners Singapore Pte. Ltd. acquired a new stake in shares of Agilon Health during the 2nd quarter worth $31,000. Finally, Legal & General Group Plc raised its position in shares of Agilon Health by 4.1% in the 2nd quarter. Legal & General Group Plc now owns 346,031 shares of the company’s stock worth $796,000 after buying an additional 13,700 shares during the period.

Wall Street Analysts Forecast Growth

A number of equities analysts recently issued reports on AGL shares. BTIG Research reissued a “neutral” rating on shares of Agilon Health in a report on Friday, December 12th. Royal Bank Of Canada raised Agilon Health from a “hold” rating to a “moderate buy” rating in a report on Wednesday, December 3rd. Weiss Ratings reaffirmed a “sell (e+)” rating on shares of Agilon Health in a report on Wednesday, January 21st. Wells Fargo & Company lifted their price objective on shares of Agilon Health from $1.00 to $1.50 and gave the company an “overweight” rating in a research report on Friday, February 27th. Finally, Barclays dropped their price objective on shares of Agilon Health from $1.00 to $0.50 and set an “underweight” rating on the stock in a research note on Friday, February 27th. Three investment analysts have rated the stock with a Buy rating, eleven have issued a Hold rating and two have assigned a Sell rating to the company’s stock. According to MarketBeat.com, the company currently has a consensus rating of “Hold” and an average price target of $2.18.

About Agilon Health

Agilon Health (NYSE: AGL) is a healthcare company that partners with independent primary care physicians to deliver value-based care for Medicare beneficiaries. Through risk-sharing arrangements, Agilon assumes financial responsibility for patient populations, enabling physicians to focus on preventive and proactive health management. The company provides the administrative, clinical and operational infrastructure needed to support comprehensive care delivery.

Agilon’s platform encompasses data analytics, care management, patient engagement tools and population health programs.